DARA SC: Clinical Trials

1 trial of DARA SC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow DARA SC: new trials by email Literature Review of DARA SC trials Research Report on DARA SC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
DARA SC - Multiple Myeloma
Phase 1CompletedJanssen Pharmaceutical K.K.62017-08-102023-04-14

Conditions studied

Multiple Myeloma (1)

Sponsors

Janssen Pharmaceutical K.K. (1)

Countries

Japan (1)

Results publications

PMID 32915384, PMID 37022569